Clinical Trials Directory

Trials / Completed

CompletedNCT03774004

Plaque Burden Pre- Myocardial Revascularisation

Association of Peripheral Atherosclerotic Burden With the Short-term and Long-term Outcome in Patients With Elective Myocardial Revascularisation

Status
Completed
Phase
Study type
Observational
Enrollment
252 (actual)
Sponsor
Medical University Innsbruck · Academic / Other
Sex
All
Age
30 Years – 85 Years
Healthy volunteers

Summary

The study is a prospective-observational, explorative single-centre cohort study aimed to examine the influence of the peripheral atherosclerotic plaque volume on short and long term morbidity and mortality in patient after coronary artery bypass grafting (CABG). Atherosclerotic disease (IMT, plaque volume) will be measured with a ultrasound system (IMT measurements and 3D quantitative plaque volumetric). Hemodynamic and flow profiles of the internal thoracic arteries will be evaluated additionally with US. These parameters will be measured pre-CABG. Morbidity will be evaluated using quality of life questionnaires (EQ-5D-3L, IPAQ). Major adverse cardiovascular events (MACE) will be the primary endpoint. The atherosclerotic burden will be compared with established risk scores (EuroSCORE, STS-Score, SYNTAX Score, FORECAST.

Conditions

Timeline

Start date
2018-09-01
Primary completion
2020-12-31
Completion
2021-07-01
First posted
2018-12-12
Last updated
2023-10-23

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT03774004. Inclusion in this directory is not an endorsement.

Plaque Burden Pre- Myocardial Revascularisation (NCT03774004) · Clinical Trials Directory